Insights On CONTRACT PHARMA MANUFACTURING

  1. TARGATT™, CRISPR/Cas9 Modified iPSCs For Genetic Disease Modeling 10/3/2025

    See how CRISPR/Cas9 and TARGATT™ technologies achieve precise gene editing in induced pluripotent stem cells (iPSCs), thus improving disease modeling and accelerating therapeutic development.

  2. Liquid Phase Peptide Synthesis: Regulatory, Analytical, And QC Perspectives 10/3/2025

    Discover how Liquid Phase Peptide Synthesis (LPPS) uses traditional reactors to create more efficient and sustainable peptide manufacturing. Learn about key analytical and quality control considerations.

  3. 5 Benefits Of Leveraging Machine Learning In Your Process Development Workflows 10/2/2025

    To maximize the impact of AI on early drug development, work with a CDMO that is already activating this technology to improve timelines, ensure reliability, and manufacture a high-quality product.

  4. What Are The Keys To Making Rare Disease Drug Development Sustainable? 9/30/2025

    This roundtable weaves together diverse perspectives, providing a multifaceted look at what it will take to create a sustainable path forward in rare disease drug development.

  5. Manufacturing Strategies To Industrialize Autologous Therapies 9/30/2025

    Discover how a systematic approach to autologous cell therapy manufacturing can reduce costs, improve reliability, and accelerate access to life-changing treatments.

  6. Improving Methodologies For iPSC Manufacturing And Differentiation 9/30/2025

    Learn how next-generation workflows are being developed to streamline iPSC manufacturing, enhance differentiation strategies, and overcome the hurdles of scalability and consistency.

  7. Nitrosamines: Assessing The Risk To Pharma Products 9/25/2025

    Nitrosamines are a serious risk in drug products, driven by the presence of secondary amines, conducive conditions, and nitrosating agents. Understanding these factors is key to risk mitigation and patient safety.

  8. Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency 9/25/2025

    Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.

  9. Optimizing Charge And N-glycan Profiles For CHO-Derived Fusion Proteins 9/24/2025

    Discover how structured design-of-experiment approaches can optimize charge variants and glycosylation to enhance biologics quality and therapeutic performance.

  10. Not A Trick Question: How Do You Know When You Have Adequately Established A Reliable Supply Chain? 9/23/2025

    Leave it to an Outsourced Pharma Live digital discussion to ask the questions others leave out. How much de-risking is too much? When can you sleep at night knowing your supply chains are as they should be, and you can fully rely on them? Oh, and we answer questions such as these as well.